Clinical Study
Prolonged Therapy with Imatinib Mesylate before Surgery for Advanced Gastrointestinal Stromal Tumor Results of a Phase II Trial
Table 3
Surgical strategy before and after neoadjuvant imatinib, resection performed, and resection margins.
| Patient | Number of organs planned to be resected before NAIi (details) | Number of organs planned to be resected after NAI (details) | Changes in resection due to NAI | Number of organs resected | Resection margins |
| 1 | 1ii (with colostomy) | 1iii (no colostomy) | | 1 | R0 | 2 | 1 (STGiv) | 1 (WGv) | | 1 | R0 | 3 | 1 (STG) | 1 (WG) | | 1 | R0 | 4 | 4 (Whipple, RCvi, kidney) | 3 (Whipple, RC) | | 3 | R0 | 5 | 3 (STG, SPvii, and PAviii) | 3 (WG, SP, and PA) | | 3 | R0 | 6 | 1 (antrectomy) | 1 (antrectomy) | = | 0ix | NAx | 7 | 2 (stomach + liver) | 2 (stomach + liver) | = | 0xi | NA | 8 | 2 (STG + left liver) | 2 (STG + left liverxii) | = | 2 | R0 | 9 | 1 (liver) | 1 (liver) | = | 1 | R0 | 10 | 4 (oesophagectomy + trachea + pericardia + vertebral body) | 1 (oesophagus) | | 1 | R0 | 11 | 2 (Whipple) | 2 (Whipple) | = | 0xiii | NA | 12 | 2 (STG + PA) | 1 (STG) | | 1 | R0 | 13 | 3 (STG + SP + PA) | 3 (STG + SP + PA) | = | 3 | R0 | 14 | 1 (antrectomy) | | | | |
|
|
iNAI: neoadjuvant imatinib.
iiAbdominoperineal resection.
iiiLow anterior resection with primary anastomosis.
ivSTG: subtotal gastrectomy.
vWG: wegde gastrectomy.
viRC: right hemicolectomy.
viiSP: spleen.
viiiPA: pancreas.
ixPatient refused laparotomy.
xNot applicable.
xiNR: nonresectable due to multiple liver metastasis.
xiiSemielective procedure for gastric bleeding.
xiiiPatient refused Whipple procedure (segmental duodenal resection was not possible).
|